May
25
Friday

REGN 293.74 -0.87 (-0.30%)

Sections on this page: Stock Price | Stock Charts | Company Profile | Earnings


Would you like to receive important updates about Regeneron Pharmaceuticals Inc like earnings dates and more?

Add (REGN) to Portfolio

REGN Stock Price Today $293.74

 The recent REGN stock price today is $293.74 -0.87 (-0.30%) for Fri, May 25, 2018.

Year To Date

The Year To Date (YTD) return is -23.23%.

52 Week Low

May
09
Wednesday

The 52 Week Low stock price is 281.89 set on Wed, May 9, 2018 which is 17 days ago.

The current price per share is 4.20% above the 52 week low.

52 Week High

Jun 2017
22
Thursday

The 52 Week High stock price is $543.55 set on Thu, Jun 22, 2017 which is 338 days ago.

The current price per share is -45.96% below the 52 week high.

All Time High

Aug 2015
04
Tuesday

The All Time High stock price is $605.93 set on Tue, Aug 4, 2015 which is 1,026 days ago.

The current price per share is -51.52% below the all time high.

Regeneron Stock Charts

The 5 year and 1 year stock charts are below.

5 Year Stock Chart

The Regeneron 5 year stock chart shows the historical prices over the previous 60 months.

Regeneron 5 year stock chart

1 Year Stock Chart

The Regeneron 1 year stock chart shows the historical prices over the previous 12 months.

Regeneron 1 year stock chart

50 Day Moving Average

The 50 Day Moving Average is at $314.39 which is 6.57% above the stock price of $293.74.

200 Day Moving Average

The 200 Day Moving Average is at 378.61 which is 22.42% above the stock price of $293.74.

REGN Company Profile

Regeneron Pharmaceuticals Inc LogoRegeneron Pharmaceuticals Inc is a Health Care stock that trades on the NASDAQ and has a market capitalization of $31.68 Billion.

http://www.regeneron.comRegeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

For more information and analysis about Regeneron Pharmaceuticals Inc, visit their web site at http://www.regeneron.com. For a real time price lookup on this ticker, REGN, visit Google Finance and Bloomberg.

Below are several other Biotech & Pharma stocks include AbbVie Inc (ABBV), Allergan PLC (AGN), Alexion Pharmaceuticals Inc (ALXN), Amgen Inc (AMGN), Biogen Inc (BIIB), BioMarin Pharmaceutical Inc (BMRN), Bristol-Myers Squibb Co (BMY), Celgene Corp (CELG), Endo International PLC (ENDP), Gilead Sciences Inc (GILD), .

REGN Earnings

 Below is the EPS, P/E Ratio and Earnings Date.

Earnings Per Share

The EPS is $10.34.

Price To Earnings Ratio

The P/E Ratio is 28.41

Earnings Dates

Stocks can make big percentage moves on the earnings announcement.

Companies announce earnings either before the market open or after the close.

Feb
08
Thursday

The Earnings Release Date for Regeneron Pharmaceuticals Inc was Thu, Feb 8, 2018.

Since this earnings release 107 days ago, the stock price is down by -12.21%.

May
03
Thursday

The most recent Earnings Release Date was on Thu, May 3, 2018, which was 23 days ago.

Since this earnings date, the stock price is down by -0.81%.

Regeneron Dividend

REGN currently does not pay a dividend.

You may like this list of best dividend stocks of 2018.